antitumor activities, in particular against prostate cancer cell lines [10]. It inhibits thymidine uptake in murine 1 Albert-Ludwigs-Universität Institut für Pharmazeutische Wissenschaften smooth-muscle cells and cell-cycle progression. Its unusual activities depend on the long oligosaccharide Stefan-Meier-Strasse 19 79104 Freiburg chain because landomycins with shorter sugar chains, such as landomycin E (Figure 1) produced by S. globi-Germany 2 Institut of Chemistry and Chemical Technologies sporus, have much weaker antitumor activity [11]. The sugar portion consists of four D-olivose and two National University Lvivs'ka Politechnika L-rhodinose moieties (Figure 1). Its formation is extremely puzzling because only four glycosyltransfer-St. Jury sq. 3/4 Lviv 79000 ases (LanGT1, LanGT2, LanGT3, and LanGT4) are available for the six consecutive elongations steps toward Ukraine the hexasaccharide [12]. By heterologous expression and gene inactivation, Summary we could recently demonstrate that LanGT2 is the priming glycosyltransferase connecting D-olivose to the Detailed studies on the biosynthesis of the hexalandomycin aglycon [13]
Introduction the fifth and sixth chain-elongation step.
In this paper, we report results that answer the riddle Sugar modifications of many antibiotics play essential of the "six sugars, four glycosyltransferases" paradox: roles in maintaining the biological activities of these it is shown by feeding experiments that LanGT1 and compounds [1] . It has been clearly demonstrated that LanGT4 are iteratively acting enzymes both catalyzing anthracyclines, glycopeptide antibiotics, aminocoumathe attachment of two sugar moieties during landorines, and macrolides require sugar moieties for their mycin A maturation. We also present data on LanZ2, full biological activities [2, 3]. A small but growing numwhich apparently controls the smooth course of the ber of natural products with promising antibacterial biosynthesis of the hexasaccharide side chain. activities mainly consists of sugar chains. Examples for such oligosaccharide antibiotics are the orthosomycins
Results avilamycin A and evernimicin, the huge polysaccharide saccharomycin, and the angucyclines urdamycin A and Feeding Experiments Revealed LanGT1 and LanGT4 landomycin A [3-5].
to Be Iteratively Acting Glycosyltransferases A fundamental challenge in the field of oligosacchaof the Landomycin A Pathway ride antibiotics is to identify the exact functions of gly-If one considers that the hexasaccharide side chain of cosyltransferases that are involved in the biosynthesis landomycin A is built up by six consecutive glycoof the glycan structures. Biosynthetic gene clusters of syltransfers, it is impossible to identify an iteratively a few oligosaccharide antibiotics have been cloned and acting GT solely by inactivation of the respective gene sequenced [6-8]. But only the biosynthesis of the urdabecause the chain elongation would always be stopped mycin sugar side chain has been investigated in detail, prior to its first glycosyltransfer. No information of a poand it was shown that one glycosyltransferase is tential second glycosyltransfer would be provided. needed for the attachment of each individual sugar [6].
Feeding experiments with landomycin derivatives with In this study, we are presenting data on the biosynvarying chain length were performed as an alternative thesis of landomycin A, a compound containing a hexastrategy to overcome this limitation. Landomycin E, containing a trisaccharide side chain, was fed to the 
cyanogenus. The chain elongation of fed landomycin plasmid pKC1132lanZ2 (Experimental Procedures) carrying the deleted lanZ2 gene and the chromosomal al-derivatives was monitored by HPLC-MS. Feeding of landomycin E to the wt strain led to its conversion to lando-
lele of this gene in S. cyanogenus S136. The mutated region in lanZ2 was confirmed by PCR and sequenc-mycin A (data not shown). This demonstrates that S. cyanogenus S136 is able to convert truncated landomycin ing analysis. For complementation, plasmid pKCermE-GT3Z2Z3 consisting of lanZ2 ligated behind the ermE derivatives to the full-length final product. However, feeding of landomycin E to the lanGT1 mutant resulted promotor was introduced into the mutant strain by intergeneric conjugation. This led to the complete recon-in the accumulation of landomycin I, the tetrasaccharide congener. This indicates that the fifth sugar stitution of landomycin A production. The HPLC-MS analyses of the lanZ2 mutant revealed transfer cannot take place in the absence of LanGT1. Hence, we conclude that LanGT1 catalyzes also the the production of a different spectrum of landomycin derivatives compared to the wt strain. The wt strain was fifth glycosyltransfer additionally to the second as previously shown (Figure 2A ). After feeding of landomycin producing landomycin A (44%), landomycin B (30%), and landomycin D (26%). The lanZ2 mutant produced E to the lanGT4 mutant, landomycin B containing five sugars was accumulated. This shows that the final gly-landomycin A (5.4%), landomycin B (7%), and landomycin D (4%) and, in addition, landomycin F (23.4%) cosyltransfer depends on the presence of LanGT4. From this result, we can conclude that LanGT4 is also and landomycin E (30%). The latter have both never been described as products of the wt strain. Further-responsible for the terminal L-rhodinosyltransfer (Figure 2B) . This data clearly documents that both GTs more, two new landomycin derivatives with unknown structure (30.2%) were produced. From these results, LanGT1 and LanGT4 are iteratively acting during the hexasaccharide formation of landomycin biosynthesis.
we have to conclude that LanZ2 impacts the formation of the sugar side chain.
Inactivation of lanZ2 Results in the Production of Novel Landomycin Derivatives
Discussion The identification of the function of LanZ2, a protein resembling dNDP-hexose synthases from different clus-The hexasaccharide portion of landomycin A is the longest sugar side chain so far detected among angu-ters [8] , was aimed by targeted gene disruption. This was achieved by homologous recombination between cycline and anthracycline antibiotics. In our work, we pression [17] or by in vitro studies [18] . But to date, no was chosen for targeted inactivation by shifting the reading frame. the cell.
GT has been shown to act twice during natural product

